Top compounds associated with response to UBE2L3


Feature Type Standardized
Nominal ANOVA
mRNA Imatinib GDSC1000 pan-cancer AAC 0.2 0.0002
mRNA Axitinib FIMM pan-cancer AAC 0.44 0.003
mRNA BRD-K16147474 CTRPv2 pan-cancer AAC 0.11 0.004
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.09 0.005
mRNA ciclosporin CTRPv2 pan-cancer AAC -0.1 0.006
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.097 0.009
mRNA GSK269962A GDSC1000 pan-cancer AAC 0.083 0.009
mRNA Dasatinib CTRPv2 pan-cancer AAC 0.092 0.009
mRNA SB-743921 CTRPv2 pan-cancer AAC 0.083 0.01
mRNA rigosertib CTRPv2 pan-cancer AAC 0.083 0.01
Download CSV